These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22386032)

  • 41. Compulsory vaccination, the constitution, and the hepatitis B mandate for infants and young children.
    Hollan M
    Yale J Health Policy Law Ethics; 2012; 12(1):39-86. PubMed ID: 22679659
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1709-11. PubMed ID: 22189894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determining the point of indifference--where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise.
    Varghese RM; Abraham J; James J; Puliyel JM
    Indian J Gastroenterol; 2004; 23(4):154-6. PubMed ID: 15333982
    [No Abstract]   [Full Text] [Related]  

  • 44. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-dose hepatitis vaccination versus 3-dose regimen.
    Meyerhoff AS; Greenberg DP
    Pediatrics; 2002 Jun; 109(6):1183-4; author reply 1183-4. PubMed ID: 12042564
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule.
    Gomber S; Sharma R; Ramachandran VG; Talwar V; Singh B
    Indian Pediatr; 2000 Apr; 37(4):411-3. PubMed ID: 10781235
    [No Abstract]   [Full Text] [Related]  

  • 47. Should Europe have a universal hepatitis B vaccination programme?
    Van Damme P; Leuridan E; Hendrickx G; Vorsters A; Theeten H; Leino T; Salminen M; Kuusi M
    BMJ; 2013 Jul; 347():f4057. PubMed ID: 23843546
    [No Abstract]   [Full Text] [Related]  

  • 48. Assessment of hepatitis B vaccine coverage by using the national immunization day in Chandigarh.
    Bhatia V; Swami HM
    Indian J Med Sci; 2000 Aug; 54(8):347-9. PubMed ID: 11143750
    [No Abstract]   [Full Text] [Related]  

  • 49. [National hepatitis B vaccination closer to implementation, but not soon enough: recommendations from the Dutch Health Council].
    Gunning-Schepers LJ; Houweling H
    Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1572-3. PubMed ID: 11525094
    [No Abstract]   [Full Text] [Related]  

  • 50. [The economic aspects of vaccination against hepatitis B].
    Zhiburt EB
    Voen Med Zh; 1997 Aug; 318(8):22-4. PubMed ID: 9424810
    [No Abstract]   [Full Text] [Related]  

  • 51. Automated interviewing for hepatitis B risk assessment and vaccination referral.
    Havel RD; Wright MP
    Am J Prev Med; 1997; 13(5):392-5. PubMed ID: 9315273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Universal hepatitis B vaccination.
    Piazza M
    Lancet Infect Dis; 2008 Feb; 8(2):88-9; author reply 90. PubMed ID: 18222158
    [No Abstract]   [Full Text] [Related]  

  • 53. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board.
    Van Damme P; Kane M; Meheus A
    BMJ; 1997 Apr; 314(7086):1033-6. PubMed ID: 9112852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost effectiveness of hepatitis B immunisation strategies.
    Hillman AL; Blasco I; Bloom BS; Schwartz JS
    Pharmacoeconomics; 1994 Feb; 5(2):85-7. PubMed ID: 10146900
    [No Abstract]   [Full Text] [Related]  

  • 55. Utility of hepatitis B vaccination in India.
    Kumar R; Puliyel J
    Indian Pediatr; 2014 Nov; 51(11):870-2. PubMed ID: 25432214
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B vaccination: time for a booster?
    Shopper T
    LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
    [No Abstract]   [Full Text] [Related]  

  • 57. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
    Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relevance of Japan's hepatitis vaccine policy to national Hepatitis B prevention and control.
    Takahashi K; Kobayashi J; Sugiura Y
    J Public Health Policy; 2012 Feb; 33(1):136-8. PubMed ID: 22282169
    [No Abstract]   [Full Text] [Related]  

  • 59. Developed countries could pay for hepatitis B vaccination in developing countries.
    Gay NJ; Edmunds WJ
    BMJ; 1998 May; 316(7142):1457. PubMed ID: 9572767
    [No Abstract]   [Full Text] [Related]  

  • 60. The importance of a preschool booster for children born to hepatitis B-positive mothers.
    Ladhani SN; Ramsay ME
    Arch Dis Child; 2013 Jun; 98(6):395-6. PubMed ID: 23625988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.